BFC
PTX

Bedel Financial Consulting’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Bedel Financial Consulting’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-7
Closed – – 744
2018
Q4 		$0 Hold
7
– – ﹤0.01% 743
2018
Q3 		$0 Hold
7
– – ﹤0.01% 742
2018
Q2 		$0 Hold
7
– – ﹤0.01% 742
2018
Q1 		$0 Buy
+7
New +$18 ﹤0.01% 704

Bedel Financial Consulting's PTX Position: Q1 2019 in Review

Bedel Financial Consulting sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2019, closing a stake of 7 shares.

Bedel Financial Consulting first reported a position in PTX in Q1 2018 and held it in 4 quarters. The position peaked at $0 in Q4 2018. 1 fund tracked by Wall St. Rank holds PTX as of Q1 2019.

  • Bedel Financial Consulting reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
  • Bedel Financial Consulting sold 7 Pernix Therapeutics Holdings, Inc. shares in Q1 2019.
  • Bedel Financial Consulting first reported a position in Pernix Therapeutics Holdings, Inc. in Q1 2018 and held it in 4 quarters.
  • Bedel Financial Consulting's Pernix Therapeutics Holdings, Inc. position peaked at $0 in Q4 2018.
  • 1 fund tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2019.

Based on Bedel Financial Consulting's 13F filing for Q1 2019, filed 2 May 2019.